Dr. Joshua Shipley
Overview
Joshua Shipley, MD, specializes in hematology oncology and is board-certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center and is affiliated with UPMC Lititz, UPMC Hanover, UPMC West Shore, UPMC Community Osteopathic, and UPMC Harrisburg. Dr. Shipley received his medical degree from Drexel University College of Medicine and completed his residency program and fellowship program at the Warren Alpert Medical School of Brown University.
Dr. Shipley is highly rated in 25 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Childhood Iron Deficiency Anemia.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1575 Highlands Drive, Suite 205, Lititz, PA 17543
310 Stock Street, Suite 5, Hanover, PA 17331
2020 Technology Parkway, Suite 3200, Mechanicsburg, PA 17050
Cancer Care Associates Of York
Daniel N. Efiom-Ekaha, MD, specializes in hematology oncology. He is affiliated with UPMC Memorial. Dr. Efiom-Ekaha completed his fellowship at SUNY at Albany, residencies at The Brooklyn Hospital Center and Royal College of Obstetricians and Gynaecologists and medical degree at the University of Ibadan College of Medicine. Dr. Efiom is highly rated in 51 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, and Bone Marrow Aspiration.
Lancaster Cancer Center
Hyatt Degreen is a Hematologist Oncology provider in Lancaster, Pennsylvania. Dr. Degreen is highly rated in 52 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma.
Cancer Care Associates Of York
Chanh Huynh is a Hematologist Oncology specialist and an Oncologist in York, Pennsylvania. Dr. Huynh has been practicing medicine for over 22 years is highly rated in 74 conditions, according to our data. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Joshua Shipley
How do I make an appointment with Dr. Joshua Shipley?
You can book an appointment with Dr. Joshua Shipley by calling their office at 717-625-5850. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Joshua Shipley a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joshua Shipley is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Joshua Shipley specialize in?
While Dr. Joshua Shipley is a Hematology Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Joshua Shipley accept my insurance?
Dr. Joshua Shipley accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 717-625-5850 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Shipley isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Shipley isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Shipley isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Shipley isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Shipley isAdvanced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Shipley isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- ChoriocarcinomaDr. Shipley isAdvanced. Learn about Choriocarcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Shipley isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Shipley isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Shipley isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Shipley isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Shipley isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Immune ThrombocytopeniaDr. Shipley isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Shipley isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.